BABA, DICE, CAR, and Beyond

Signage at the Alibaba Group Holding Ltd. offices in Beijing, China, on Tuesday, Jan. 17, 2023. Bloomberg | Bloomberg | Getty Images Discover the companies with remarkable movements in premarket trading: Alibaba — The shares of this U.S.-listed e-commerce giant dropped 2.3% after the announcement of CEO Daniel Zhang’s resignation. Eddie Wu, one of Alibaba’s …

Read more

Dice Therapeutics to be acquired by Eli Lilly in $2.4 billion deal

David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC Eli Lilly announced on Tuesday that it has entered into a strategic deal valued at $2.4 billion to acquire Dice Therapeutics . This strategic move will strengthen Eli Lilly’s treatment portfolio for immune-related diseases. The deal will involve Eli Lilly acquiring Dice Therapeutics at a price …

Read more

Drug manufacturers seek to combat Medicare negotiations at Supreme Court

On February 26, 2019, the Chief Executive Officers (CEOs) of prominent pharmaceutical companies appeared before the Senate Finance Committee in Washington, DC for a hearing on “Drug Pricing in America: A Prescription for Change, Part II.” The CEOs in attendance included Richard A. Gonzalez of AbbVie Inc, Pascal Soriot of AstraZeneca, Giovanni Caforio of Bristol-Myers …

Read more

Possible rewrite: Potential negative impact on drug development due to Medicare price negotiations

David Ricks, CEO of Eli Lilly, expresses concerns over potential harm to drug development caused by Medicare price negotiations aimed at reducing costs for older Americans. Ricks, in an interview on CNBC’s “The Exchange,” stated, “I’m really worried about the harm this will do to new cures and possibilities in medicine.” The provision in focus …

Read more